20 research outputs found
Risk assessment in contemporary outpatients with non-valvular atrial fibrillation recently on vitamin K antagonists
Get PDFAtrial Fibrillation increases the risk of embolic stroke by five fold. Vitamin K
antagonists (VKAs) are still the most used oral anticoagulants in patients with nonvalvular
atrial fibrillation (NVAF) and are highly effective for the prevention of
thromboembolic (TE) complications in these patients. However, achieving the best
benefit and safety from VKAs in the clinical practice remains a major challenge mainly
because of their unpredictable anticoagulant response. In this thesis, we aimed to
evaluate the quality of oral anticoagulation in a real world cohort of patients with
NVAF recently on VKAs and to assess the risk of TE and major bleeding complications
in a contemporary cohort of outpatients with NVAF anticoagulated with VKAs.
Furthermore, in this thesis we also aimed to assess the usefulness and reliability of
different contemporary risk estimation scales in atrial fibrillation
Characterizing patients who do not do well on a vitamin-K antagonist therapy in a community based cohort of patients with non valvular atrial fibrillation
No full text
CHA2DS2-VASc vs. CHADS2 at predicting the risk of stroke and death in a community-based cohort of patients with non-valvular atrial fibrillation who are on anticoagulation
No full textUsefulness of the SAMe-TT2R2 risk score in identifying patients who will do well with vitamin K antagonist therapy in a community-based cohort of patients with non-valvular atrial fibrillation
No full textComparative evaluation of HAS-BLED and ATRIA scores by investigating the full potential of their bleeding prediction schemes in non-valvular atrial fibrillation patients on vitamin-K antagonists
No full textEvaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists
No full textPrognostic usefulness of the glomerular filtration rate estimation equations in patients with non-valvular atrial fibrillation on vitamin K antagonists: The new CKD-EPI versus the re-expressed MDRD-4
No full textRenal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs reexpressed 4 variable modification of diet in renal disease
No full textPrognostic impact of female gender on a contemporary cohort of Spanish patients with acute myocardial infarction
No full text
